​

Sharps Stock (NASDAQ:STSS)

OwnershipFinancialsChart
Sharps by TradingView

Previous Close

$5.05

52W Range

$3.30 - $1.25K

50D Avg

$7.71

200D Avg

$68.59

Market Cap

$130.34M

Avg Vol (3M)

$1.39M

Beta

2.16

Div Yield

-

STSS Company Profile

Sharps Technology Inc., a medical device company, researches, designs, develops, manufactures, distributes, and sells safety syringe products in the United States. It offers Sharps Provensa, an ultra-low waste space syringe for the administration of various vaccines and injectable medications. The company was incorporated in 2017 and is based in Melville, New York.

Show More

Industry

Medical - Instruments & Supplies

Sector

Healthcare

Exchange

NASDAQ

ADR

-

Country

US

Employees

55

IPO Date

Apr 14, 2022

Website

STSS Performance

STSS Financial Summary

Dec 24Dec 23Dec 22
Revenue---
Operating Income$-9.63M$-10.13M$-8.74M
Net Income$-9.30M$-9.84M$779.88K
EBITDA$-9.63M$-8.98M$-2.66M
Basic EPS$-7.40$-0.76$0.10
Diluted EPS$-7.40$-0.76$0.10

Fiscal year ends in Dec 24 | Currency in USD

Peer Comparison

TickerCompany
CBIOCrescent Biopharma, Inc.
MBOTMicrobot Medical Inc.
AVRAnteris Technologies Global Corp.
CRDFCardiff Oncology, Inc.
KRMDKORU Medical Systems, Inc.
OWLTOwlet, Inc.
NVCTNuvectis Pharma, Inc.
HYPRHyperfine, Inc.
UTMDUtah Medical Products, Inc.